Background and objective: Serum periostin is increased in asthma and serves as a surrogate marker for IL-13 activity in the lung. Serum levels of periostin are the most robust biomarker predicting a favourable response to the anti-IL-13 drug, lebrikizumab. We investigated the mechanisms of IL-13 stimulation of periostin, the polarized secretion of periostin and whether periostin would have a direct effect on mucin secretion by airway cells. Methods: Normal human bronchial epithelial (NHBE) cells were cultured at air-liquid interface (ALI) in the presence of IL-13, and we evaluated the effect of the specific inhibitors, leflunomide (Janus kinase (JAK)/signal transducer and activator of transcription factor 6 (STAT6) inhibitor) or PD98059 (MEK/extracellular regulated protein kinase (ERK) inhibitor), on periostin production. We examined MUC5AC secretion from NHBE cells exposed to recombinant human (rh) periostin or IL-13 in the presence and absence of OC-20, a periostin-neutralizing antibody. Results: IL-13 induced periostin protein which was predominantly secreted towards the basal surface of the cells. Periostin production was much greater from goblet cells than ciliated cells (P < 0.001). Periostin production after exposure to IL-13 was attenuated by both leflunomide (P < 0.001) and PD98059 (P < 0.001). The addition of exogenous periostin modestly increased MUC5AC secretion (P < 0.01), but did not visibly change cell morphology. IL-13-induced MUC5AC secretion was attenuated by OC-20 (P < 0.01). Conclusion: Periostin production in differentiated airway cells is mediated by JAK/STAT6 and MEK/ERK pathways. Periostin secretion is much greater from immunologically active goblet cells. IL-13-driven mucin production is partially inhibited by OC-20.
INTRODUCTION
Asthma is characterized by airway hyperresponsiveness (AHR), eosinophilic inflammation, airflow limitation and mucus hypersecretion. 1, 2 Prolonged airway inflammation can lead to airway remodelling including subepithelial fibrosis from extracellular matrix deposition, airway smooth muscle hypertrophy and goblet cell metaplasia (GCM). 3 The helper T-cell type 2 (TH2) cytokine, IL-13, plays a pivotal role in the pathogenesis of asthma by inducing AHR, airway inflammation and GCM. [4] [5] [6] Periostin, a 90-kDa member of the fasciclincontaining family, is a protein that not only interacts with other extracellular matrix proteins to maintain tissue structure but also contributes to fibrosis, eosinophil activation and recruitment, and to TH2-driven inflammation. [7] [8] [9] [10] In the airway, periostin is secreted by fibroblasts and epithelial cells and secretion is increased by IL-4 and IL-13.
11-13 Although periostin appears to play an important role in the pathogenesis of asthmatic airway inflammation and tissue remodelling, the airway cellular source of periostin, the signalling mechanisms responsible for IL-13 induction of airway periostin production and the effect of periostin on mucin secretion are not well studied.
IL-13 stimulates mucin secretion and clinical studies suggest that periostin and IL-13 are increased in severe asthma. 6, [14] [15] [16] Also, the goblet cell appears to be an immune effector cell. 17 Therefore, we hypothesized that periostin would be secreted from differentiated airway epithelial cells exposed to IL-13, that periostin secretion would be greater in goblet cells than in ciliated cells and that exogenous periostin would stimulate GCM and mucin secretion.
METHODS

Reagents
The following reagents were purchased from the indicated companies: recombinant human (rh) IL-13 (R&D Systems, Inc., Minneapolis, MN, USA.); rhperiostin (R&D Systems); mouse anti-periostin monoclonal antibody OC-20 (Sirius-Biotech, Genoa, Italy) [18] [19] [20] ; mouse IgM, k isotype antibody (Biolegend, San Diego, CA, USA); phospho-and non-phosphospecific signal transducer and activator of transcription factor 6 (STAT6), phospho-and non-phospho-specific extracellular regulated protein kinase (ERK) 1/2 and anti-rabbit-IgG HRP antibodies (Cell Signaling Technology, Inc., Beverly, MA, USA); DMEM, Ham's F12 medium (Gibco, Grand Island, NY, USA); bronchial epithelial cell growth medium, SingleQuotR kit and Hanks' balanced salt solution (HBSS) (Lonza Walkersville, Inc., Walkersville, MD, USA); leflunomide (Sigma-Aldrich Co., St. Louis, MO, USA); PD98059 (Calbiochem, La Jolla, CA, USA) and dimethylsulphoxide (DMSO) (Sigma-Aldrich Co.).
NHBE cell culture
Normal human bronchial epithelial (NHBE) cells (Lonza Walkersville, Inc.) were cultured and differentiated into ciliated cells or goblet cells at air-liquid interface (ALI) as we previously described. 21, 22 NHBE cells were grown in bronchial epithelial cell growth medium supplemented with the SingleQuotR kit at 37 C with 5% CO 2 . The medium was changed every 48 h, and the cells were cultured until 70-80% confluence. At the second passage, the cells were seeded to polyester membrane transwell-clear inserts (Corning, Lowell, MA, USA). NHBE cells were then cultured in DMEM/Ham's F12 medium with 1% insulin-transferrin-selenium A, recombinant epidermal growth factor (0.5 ng/mL), triiodothyronine (10 ng/mL), hydrocortisone (0.5 μg/mL), all-trans retinoic acid (1.0 × 10 −7 mol/L), bovine serum albumin (BSA) (2.0 μg/mL) and bovine pituitary extract (30 μg/mL). After achieving 70-80% confluence, the apical side of the medium was removed and the cells were cultured at an ALI.
IL-13, periostin and OC-20 exposure
NHBE cells grown for 14 days were exposed to IL-13 (0, 5, 10 or 20 ng/mL) for 1 or 14 days. The medium with IL-13 was changed every 48 h. To evaluate the acute effect of IL-13 on periostin production, IL-13-transformed goblet cells or ciliated cells were exposed to IL-13 or PBS for 72 h ( Fig. 2A) . For periostin exposure, NHBE cells grown for 14 days were exposed to rh-periostin (0, 0.01, 0.1 or 1 μg/mL) for 14 days. The medium with rh-periostin was changed every 48 h. For OC-20 exposure, NHBE cells were grown for 14 days in the presence of 10 ng/mL IL-13 at ALI while exposed to OC-20 at 10 μg/mL.
Treatment with either leflunomide or PD98059
NHBE cells grown with PBS for 14 days were cultured with IL-13 at 10 ng/mL and either leflunomide (40 and 120 μmol/L) or PD98059 (10 and 20 μmol/L) from the basolateral side of the inserts for 72 h before sample harvest.
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Assay for periostin
Differentiated cells were incubated with IL-13 at ALI. Culture supernatant from each well was collected by adding HBSS to the apical side of the inserts, and the culture media were collected from the basolateral side of the inserts. Periostin levels in supernatants and culture medium were measured using human periostin/ OSF-2 enzyme-linked immunosorbent assay (ELISA) DuoSet (R&D Systems).
Assay for MUC5AC
MUC5AC protein in supernatants was measured by ELISA as previously described. 23 The plates were coated with a 50-μL sample that contained bicarbonatecarbonate buffer and incubated at 37 C overnight. MUC5AC monoclonal antibody (45M1) in T-PBS was added to a concentration of 2 μg/mL and after 2 h, anti-mouse-IgG HRP-linked whole antibody was added to each well for an additional hour. 3,3 0 ,5,5 0 -Tetramethylbenzine peroxidase solution was added to the plate. The reaction was stopped with 2 N H 2 SO 4 , and the absorbance was measured using an ELx808 Ultra Microplate Reader (Bio-Tek Instruments, Winooski, VT, USA).
Real-time quantitative PCR analysis of periostin mRNA
Periostin mRNA expression was examined by real-time PCR. 23 After IL-13 exposure, the apical side of the cells was washed with PBS, and total RNA was extracted using the Aurum Total RNA Mini Kit (Bio-Rad Laboratories, Inc., Hercules, CA, USA). The total RNA was then used to synthesize the first-strand cDNA using the qScript cDNA synthesis kit (Quanta BioSciences, Inc., Gaithersburg, MD, USA). Quantitative PCR was performed on the C1000 thermal cycler equipped with CFX96 real-time PCR system (Bio-Rad). For the relative quantification of periostin mRNA expression, the expression of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) served as an internal control.
Perfecta SYBR Green (Quanta BioSciences, Inc.) was used as a DNA intercalator dye to monitor amplified DNA quantification. mRNA expression level was calculated based on a standard curve. 
Western blot analysis of STAT6 and MAPK activation and inhibition
Ciliated cells were cultured in supplement-free medium for 48 h before IL-13 exposure to avoid the influence of growth factors on cell signalling. The cell lysates were harvested 1 h after IL-13 exposure. Extraction of cell lysates and western blot analysis were performed as previously described. 21 The protein extracts underwent sodium dodecyl sulphate-polyacrylamide gel electrophoresis (SDS-PAGE) and were transferred to a nitrocellulose membrane. The membranes were blocked and incubated with phospho-STAT6 (Tyr641), STAT6, phospho-p44/42 mitogen-activated protein (MAP) kinase (MAPK) (ERK1/2) (Thr202/Tyr204) or p44/42 MAPK (ERK1/2) (Cell Signaling Technology, Inc.). The membranes were then incubated with the anti-rabbit IgG HRP secondary antibody and detected using ECL detection reagent (GE Healthcare, Piscataway, NJ, USA). Western blot images were scanned and analysed using NIH Image J software (National Institutes of Health, Bethesda, MD, USA).
Histology
Cell morphology was evaluated after haematoxylineosin (H&E) and periodic acid-Schiff (PAS) staining. 21, 23 The transwell membrane with cells was fixed in neutral 20% formalin, embedded in paraffin and then cut into 8-μm slices. The cell morphology was assessed with a light microscope (CKX41; Olympus, Tokyo, Japan) and photographed using a digital camera system (AxioCam ICc 1; Carl Zeiss, Thornwood, NY, USA).
MUC5AC expression was evaluated by immunohistochemistry. The sections were stained with anti-MUC5AC antibody as the first antibody. EnVision + Dual Link System-HRP (DAKO, North America, Inc., Carpinteria, CA, USA) was added as the secondary antibody. Antigen-antibody complexes were visualized using Liquid DAB+ Substrate Chromogen System (DAKO).
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Statistical analysis
Data are expressed as mean values AE SEM. Statistical differences were examined by one-way analysis of variance (ANOVA) as appropriate. P-values <0.05 were considered statistically significant. Statistical analysis was performed using JMP Pro9 for Windows (SAS, Cary, NC, USA).
RESULTS
Effect of IL-13 on periostin secretion from normal differentiated ciliated epithelial cells NHBE cells were cultured with PBS for 14 days at ALI to differentiate into ciliated cells and then stimulated with IL-13 at 10 ng/mL for 24, 48 and 72 h. IL-13 stimulation for 48 and 72 h significantly increased periostin in basal culture medium, but there was no detectable periostin in apical supernatants (Fig. 1A,B) . We then examined the dose response profile of IL-13-stimulated periostin production in these ciliated cells. As the concentration of IL-13 increased, the amount of periostin in the basolateral medium, but not in the apical supernatant, also increased (Fig. 1C) .
Periostin secretion from IL-13-transformed goblet cells
We have previously reported that IL-13 transforms growing NHBE cells to a goblet cell morphology, and that these goblet cells act as immune effector cells producing cytokines and chemokines. 21, 24, 25 NHBE cells were differentiated into goblet cells with IL-13 over 14 days, and then further exposed to IL-13 at 5, 10 or 20 ng/mL for 72 h after fully differentiated. IL-13 at 10 and 20 ng/mL significantly increased periostin secretion in both the apical supernatant and the basolateral medium, although basolateral secretion was far greater (Fig. 1C) . To compare the acute effect of IL-13 on periostin production in ciliated or goblet cells, transformed cells were cultured for 24 h without IL-13 and then stimulated with IL-13 at 10 ng/mL for 72 h (Fig. 2A) . The IL-13-stimulated periostin secretion from goblet cells was significantly greater than from ciliated cells (Fig. 2B) .
Effect of leflunomide on IL-13-induced periostin and STAT6 expression
In ciliated cells, leflunomide (Janus kinase (JAK)/STAT6 inhibitor) at 40 μmol/L significantly attenuated periostin production stimulated by IL-13 (Fig. 3A,B) . Ciliated . IL-13-stimulated periostin secretion from goblet cells is significantly greater than ciliated cells and periostin is predominantly secreted towards the basolateral side in both cell types. Results are means AE SEM from four samples. Significant differences are indicated by #P < 0.01, †P < 0.001, and from PBS control by *P < 0.01, ***P < 0.001. cell lysates obtained 1 h after IL-13 stimulation had increased p-STAT6 expression, and this was significantly attenuated by leflunomide at 40 μmol/L (Fig. 3C) .
Effect of PD98059 on IL-13-induced periostin and p44/42 MAPK (ERK1/2) expression
PD98059 (MEK/ERK inhibitor) at 10 μmol/L suppressed IL-13-stimulated periostin production in ciliated cells (Fig. 3D,E) . Western blot analysis of ciliated cell lysates 1 h after IL-13 stimulation increased p-ERK1/2 expression and this was significantly attenuated by PD98059 at 10 μmol/L (Fig. 3F) .
Effect of periostin on MUC5AC protein secretion and NHBE cell morphology
Addition of periostin to the basolateral side of cultured NHBE cells increased MUC5AC levels in culture supernatants in a concentration-dependent manner. This effect was modest, but statistically significant (Fig. 4A) . Of note, unlike IL-13 which transforms NHBE cells to goblet cells histologically, cells cultures with periostin were indistinguishable from ciliated cells with beating cilia and few mucin granules (Fig. 4B) . The number of PAS-positive cells and MUC5AC-positive cells modestly increased with basolateral exposure to rh-periostin at 1 μg/mL (Fig. 4B-d,f ) . Rh-periostin at 1 μg/mL did not change the cell morphology by PAS (Fig. 4B-b,d,f ) .
Effect of OC-20, a periostin-neutralizing antibody, on MUC5AC protein secretion NHBE cells were cultured for 14 days with 10 ng/mL IL-13 in the presence of OC-20 at 10 μg/mL and MUC5AC was measured in apical media. OC-20 at 10 μg/mL did not decrease cell viability (data not shown). OC-20 partially suppressed MUC5AC secretion (Fig. 5A) . The numbers of goblet cells and MUC5AC-positive cells were increased in the presence of IL-13 at 10 ng/mL (Fig. 5B-c,g ) compared with IL-13 vehicle (PBS) (Fig. 5B-a,e) . OC-20 modestly decreased the immunostaining density of IL-13-induced MUC5AC-positive cells (Fig. 5B-h) . 
Periostin production in epithelial cells
DISCUSSION
Periostin expression in the airway correlates with asthma severity and airway eosinophilia, 14, 26 and serum levels of periostin are the most robust biomarkers predicting a favourable response to the anti-IL-13 drug, lebrikizumab. 27 However, there are few studies evaluating periostin protein production from human airway epithelial cells. 12, 13 As shown in Figure 3 , IL-13-induced periostin secretion from goblet cells was much greater than ciliated cells. We previously reported that IL-13 increases the total cell numbers in this model system. The numbers of the cells cultured with PBS were 29.5 AE 0.9 cells/250 μm, and the cells cultured with IL-13 were 40.3 AE 0.7 cells/250 μm. 28 Even when we correct the amount of secretion from each cell phenotype based on total cell numbers, the periostin production from goblet cells is far greater than from ciliated cells. Although it was reported that when human airway epithelial cells are cultured with IL-13, periostin is secreted towards the basolateral side 12 ; it has also been reported that periostin secretion from airway cells is increased only apically with IL-13 exposure. 13 We confirm that IL-13-stimulated periostin production from ciliated cells is detected almost exclusively at the basolateral side, but that IL-13-transformed goblet cells can secrete periostin to both apical and basolateral sides, with basolateral secretion predominant. Periostin secreted by airway epithelial cells activates TGF-β and type 1 collagen production and is thought to be important in airway remodelling.
12 This is consistent with periostin being predominantly secreted towards the basolateral membrane of the cultured airway cells. Chronic exposure to IL-13 may decrease tight junctions in airway epithelial cells leading to transcellular 'leakage' of periostin. 29 Thus, airway epithelial cells are probably important sources of periostin in the serum and sputum of allergic ('IL-13 high') asthmatic patients.
IL-13 activates several cell signalling pathways including JAK/STAT, the phosphatidylinositol-3 (PI-3) kinase pathway and the MAPK pathway via the IL-13 receptor α 1. 30 Among these pathways, the JAK/STAT6 and MAPK pathways play key roles in asthma pathogenesis, increasing AHR, airway inflammation, mucus secretion and GCM. 5, [31] [32] [33] House dust mite-sensitized STAT6 knockout mice were unable to produce periostin after exposure to dust mite antigen. 34 Periostin production by pulmonary arterial smooth muscle cells is also reported to be mediated through PI-3 kinase and MAPK. 35 Mucus hypersecretion and GCM correlate with asthma severity and mortality. 36, 37 MUC5AC is the major gel-forming mucin expressed in goblet cells, and IL-13 increases MUC5AC-expressing goblet cells in the airways. 6, 38, 39 Periostin-deficient mice have attenuated allergen-induced airway inflammation and mucous metaplasia. 20 While this study shows that exogenous periostin increases MUC5AC secretion from human airway epithelial cells, the increase in mucin production was modest in comparison to IL-13 stimulation of these cells, and unlike IL-13, periostin did not visibly change the morphology of these cells. Thus, although periostin may contribute to IL-13-induced mucin secretion, this may not be clinically significant.
OC-20, a periostin-neutralizing antibody, blocks the interaction between periostin and its receptor integrin. [18] [19] [20] OC-20 at 2 μg/mL inhibited the binding of human melanoma cells to periostin fragments by more than 80% 19 and mice given OC-20 had less allergeninduced mucus production and airway inflammation. 20 We confirm that OC-20 attenuated IL-13-stimulated MUC5AC secretion and modestly decreased the immunostaining density of MUC5AC-positive cells by neutralizing periostin secreted by these cells into the basolateral medium (Fig. 5) . These data suggest that the role of periostin in mucus hypersecretion is limited.
In summary, we demonstrate that cultured human airway epithelial cells, in particular goblet cells, produce periostin and that this secretion is dominantly towards the basolateral membrane of the cells. Airway periostin production is regulated by both the JAK/-STAT6 and the MEK/ERK pathways. Periostin weakly stimulates mucus secretion. 
